REGULATION OF COLLAGEN MATRIX MINERALIZATION
胶原蛋白基质矿化的调节
基本信息
- 批准号:6817520
- 负责人:
- 金额:$ 29.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-07-01 至 2007-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of this study is to understand the regulatory mechanisms of collagen matrix mineralization in bones and teeth. During the last grant period, we have partially characterized the unique aspects of collagen cross-linking, and specific tissue distribution as well as mRNA expression pattern of collagen-binding small leucine-rich proteoglycans (CB-SLRPs) in mineralized tissues. These and other findings have led us to hypothesize: 1. the covalent intermolecular cross-linking of type I collagen is involved in regulating the spatial aspect of mineralization, and 2. a collagen-binding proteoglycan, decorin (DCN), partially regulates the timing and quality of collagen mineralization. To test these hypotheses, we would like: 1a. To establish osteoblastic cell clones that synthesize low levels of lysyl hydroxylase-2 to switch the cross-linking pathway from mineralized to non-mineralized tissue phenotype, 1b. To characterize the lysine hydroxylation and cross-linking chemistries (type, quantity and molecular distribution) of collagen matrix, and the mineralization pattern produced by the clones in vitro and in vivo. 2a. To investigate the roles of DCN in collagen maturation and mineralization in vitro and in vivo by employing overexpression and antisense approaches in osteoblastic cell line. 2b. To characterize the matrix mineralization (collagen and mineral) in bones/dentin in DCN-deficient and DCN/biglycan-double deficient mice. 2c. To evaluate the effects of DCN-collagen interaction on collagen maturation in vitro. The data obtained from this study may provide insights into the regulatory mechanisms of collagen mineralization in bones and teeth.
描述(由申请人提供):本研究的长期目标是了解骨骼和牙齿中胶原基质矿化的调节机制。在上一个资助期间,我们已经部分表征了胶原交联的独特方面,以及矿化组织中胶原结合的富含亮氨酸的小蛋白多糖(cb - slrp)的特定组织分布和mRNA表达模式。这些和其他的发现让我们做出假设:1型胶原的共价分子间交联参与调节矿化的空间方面;胶原结合蛋白聚糖,decorin (DCN),部分调节胶原矿化的时间和质量。为了验证这些假设,我们想:为了建立合成低水平赖氨酸羟酶-2的成骨细胞克隆,以将交联途径从矿化到非矿化的组织表型切换,1b。表征胶原基质的赖氨酸羟基化和交联化学(类型、数量和分子分布),以及体外和体内克隆产生的矿化模式。2 a。采用过表达法和反义法研究DCN在体外和体内成骨细胞系胶原成熟和矿化中的作用。2 b。表征DCN-缺陷和DCN/biglycan-双缺陷小鼠骨/牙本质中基质矿化(胶原蛋白和矿物质)。2 c。探讨dcn -胶原相互作用对体外胶原成熟的影响。从这项研究中获得的数据可能为骨骼和牙齿中胶原矿化的调节机制提供见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MITSUO YAMAUCHI其他文献
MITSUO YAMAUCHI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MITSUO YAMAUCHI', 18)}}的其他基金
Collagen Glycosylation, Maturation and Mineralization
胶原蛋白糖基化、成熟和矿化
- 批准号:
8249266 - 财政年份:2012
- 资助金额:
$ 29.2万 - 项目类别:
Collagen Glycosylation, Maturation and Mineralization
胶原蛋白糖基化、成熟和矿化
- 批准号:
8442308 - 财政年份:2012
- 资助金额:
$ 29.2万 - 项目类别:
DDR2, a Novel Collagen Receptor, and Mineralization
DDR2,一种新型胶原蛋白受体和矿化
- 批准号:
7035336 - 财政年份:2005
- 资助金额:
$ 29.2万 - 项目类别:
Biglycan: A novel modulator of osteoblast differentiation
Biglycan:成骨细胞分化的新型调节剂
- 批准号:
7140327 - 财政年份:2005
- 资助金额:
$ 29.2万 - 项目类别:
Biglycan: A novel modulator of osteoblast differentiation
Biglycan:成骨细胞分化的新型调节剂
- 批准号:
6962581 - 财政年份:2005
- 资助金额:
$ 29.2万 - 项目类别:
REGULATION OF COLLAGEN MINERALIZATION IN THE TOOTH
牙齿中胶原蛋白矿化的调节
- 批准号:
6176164 - 财政年份:1993
- 资助金额:
$ 29.2万 - 项目类别:
REGULATION OF COLLAGEN MINERALIZATION IN THE TOOTH
牙齿中胶原蛋白矿化的调节
- 批准号:
6379751 - 财政年份:1993
- 资助金额:
$ 29.2万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 29.2万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 29.2万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 29.2万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 29.2万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 29.2万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 29.2万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 29.2万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 29.2万 - 项目类别:
Studentship














{{item.name}}会员




